Brenipatide for Alcohol Use Disorder
Researchers at the University of California Los Angeles are conducting a study on Brenipatide, a GLP-1 weekly injectable investigational medication, to see if it can reduce cravings for alcohol.
Fast Facts
Drink Alcohol Regularly and Want to Stop or Cut Down
Not Currently Receiving Treatment
Compensation
Provided Up To $3984 for Study Completion
Conducted in
Los Angeles, CA
Study Background
Can Brenipatide help reduce cravings for alcohol?
Brenipatide is a GLP-1 weekly injectable investigational medication. You may have heard of GLP-1 medications in the context of managing obesity: they slow down stomach emptying, promote feelings of fullness, and reduce appetite. This research aims to find out if Brenipatide, a similar investigational medication, can reduce cravings for alcohol and alcohol consumption.
If you drink alcohol regularly and want to cut back, this study may be a good fit for you. We hope that eventually, the findings of this study might be useful for treating alcohol use disorder.
Study Background
Can Brenipatide help reduce cravings for alcohol?
Brenipatide is a GLP-1 weekly injectable investigational medication. You may have heard of GLP-1 medications in the context of managing obesity: they slow down stomach emptying, promote feelings of fullness, and reduce appetite. This research aims to find out if Brenipatide, a similar investigational medication, can reduce cravings for alcohol and alcohol consumption.
If you drink alcohol regularly and want to cut back, this study may be a good fit for you. We hope that eventually, the findings of this study might be useful for treating alcohol use disorder.
Additional Information
The goal of this study is to find out if an injectable investigational medication can help individuals with alcohol use disorder by reducing cravings for alcohol.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
- Drink alcohol regularly and want to stop or cut down
- Able to attend in-person visits at the UCLA campus for the duration of study (18 months)
- Not currently receiving treatment for alcohol problems
- Ages 21-75
In good general health
Participants will be asked to attend 21 in-person study visits and 12 remote study visits over about 64 weeks. Study procedures will include:
- Self-injecting the study investigational medication on a weekly basis
- Completing questionnaires
- Participating in interviews
- Maintaining electronic and paper study diaries
As a participant, you may receive up to $3984 for completing the entire study.
There is no cost for you to participate in our research study.